Evidence map›Paper›PMID 35332606›Full record

ArticleCell biology international2022

ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK.

Yuval Yung, Zhong Yao, Tamar Hanoch, Rony Seger

Open access · hybridAbstract read
In one paragraph

Article in Cell biology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yuval YungDepartment of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
Zhong YaoDepartment of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
Tamar HanochDepartment of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
Rony SegerDepartment of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9363-8852
Weizmann Institute of Science · IL

Funding

Israel Cancer Research Fund 102.01Minerva Foundation NA
6 · The paper itself

Abstract

The extracellular signal-regulated kinases (ERK) 1 and 2 (ERK1/2) are members of the mitogen-activated protein kinase family. Using various stimulated rodent cells and kinase activation techniques, we identified a 46-kDa ERK. The kinetics of activation of this ERK isoform was similar to that of ERK1 and ERK2 under most but not all circumstances. We purified this isoform from rat cells followed by its cloning. The sequence of this isoform revealed that it is an alternatively spliced version of the 44-kDa ERK1 and therefore we termed it ERK1b. Interestingly, this isoform had a 26-amino acid insertion between residues 340 and 341 of ERK1, which results from Intron 7 insertion to the sequence. Examining the expression pattern, we found that ERK1b is detected mainly in rat and particularly in Ras-transformed Rat1 cells. In this cell line, ERK1b was more sensitive to extracellular stimulation than ERK1 and ERK2. Moreover, unlike ERK1 and ERK2, ERK1b had a very low binding affinity to MEK1. This low interaction led to nuclear localization of this isoform when expressed together with MEK1 under conditions in which ERK1 and ERK2 are retained in the cytoplasm. In addition, ERK1b was not coimmunoprecipitated with MEK1. We identified a new, 46-kDa ERK alternatively spliced isoform. Our results indicate that this isoform is the major one to respond to exogenous stimulation in Ras-transformed cells, probably due to its differential regulation by MAPK/ERK kinase and by phosphatases.

Indexed as

MAP Kinase Signaling SystemMitogen-Activated Protein KinasesAnimalsMitogen-Activated Protein Kinase KinasesPhosphorylationProtein IsoformsRatsMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesProtein Isoformsalternative splicingERKMAPKnuclear localizationphosphorylation

Identifiers

PMID35332606
PMCPMC9320930
OpenAlexW4220850286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.